Clinical Trial Update: A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing fesoterodine for treatment satisfaction and symptom improvement in overactive bladder; completed with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Fesoterodine (fesoterodine)

Snippet

Sponsor: Pfizer | Conditions: Overactive Bladder | Phase 3 | Status: COMPLETED | Results posted: 2009-02-10